Volume 11, Number 9—September 2005
Research
Trypanosomiasis Control, Democratic Republic of Congo, 1993–2003
Pascal Lutumba*†, Jo Robays†, Constantin Miaka mia Bilenge*, Victor Kande Betu Ku Mesu*, Didier Molisho‡, Johan Declercq§, Wim Van der Veken§, Filip Meheus¶, Jean Jannin#, and Marleen Boelaert†
Table 2
Indicators for evaluating population screening for human African trypanosomiasis (HAT)*
| Indicators | |
|---|---|
| Input | Financial resources Human resources Availability of tests and anti-HAT drugs |
| Process | Identification of villages at risk Census of population at risk Involvement of population at risk in active case detection Lymph node palpation CATT test Parasitologic test for HAT confirmation Lumbar puncture to determine the stage of disease Treatment Treatment follow-up |
| Output | Coverage rate of population at risk Participation rate Identification of suspects Identification of HAT cases Proportion of HAT cases detected and treated Proportion of HAT cases treated and followed |
| Outcome | Annual HAT detection rate and trend |
*CATT, card agglutination test for trypanosomiasis; LN, lymph node palpation.
Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.